Location History:
- Jiangsu, CN (2015)
- Nanjing, CN (2018)
Company Filing History:
Years Active: 2015-2018
Title: Xueting Cai: Innovator in Pharmaceutical Composition for Cancer Treatment
Introduction
Xueting Cai is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. With a total of 2 patents, his work showcases innovative approaches to addressing critical health challenges.
Latest Patents
Xueting Cai's latest patents include a compound of Formula I or its pharmaceutically acceptable salt, along with its preparation method and applications. This new structure has not been reported in literature and is isolated from a specific source. The compound serves as a Trx1 selective inhibitor, which is crucial in the development of treatments for cancer. The invention also discloses a pharmaceutical composition that combines herbal components and chemotherapeutic compounds. This composition aims to reduce chemotherapy-induced side effects while enhancing the efficacy of anticancer drugs.
Career Highlights
Xueting Cai is affiliated with the Jiangsu Province Institute of Traditional Chinese Medicine. His work at this institution has allowed him to explore innovative solutions in traditional medicine and modern pharmaceutical applications. His research focuses on creating effective treatments that are both safe and beneficial for patients.
Collaborations
Xueting Cai collaborates with esteemed colleagues, including Peng Cao and Xiaolan Cheng, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the pharmaceutical field.
Conclusion
Xueting Cai's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight the importance of research and collaboration in advancing medical science. His patents reflect a commitment to improving patient outcomes through innovative solutions.